Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02278120
Title Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer (MONALEESA-7)
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

Her2-receptor negative breast cancer

Therapies

Goserelin + Ribociclib + Tamoxifen

Goserelin + Tamoxifen

Anastrozole + Goserelin

Goserelin + Letrozole

Goserelin + Letrozole + Ribociclib

Anastrozole + Goserelin + Ribociclib

Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL

Facility Status City State Zip Country Details
Comprehensive Blood and Cancer Center SC-2 Bakersfield California 93309 United States Details
University of California at Los Angeles Dept of Onc Los Angeles California 90095 United States Details
Comprehensive Cancer Center at Saint Joseph Hospital SC Denver Colorado 80218 United States Details
Danbury Hospital SC Danbury Connecticut 06810 United States Details
Florida Cancer Specialists Onc Dept Fort Myers Florida 33901 United States Details
Florida Cancer Specialists SC-2 Fort Myers Florida 33901 United States Details
Memorial Cancer Institute SC Hollywood Florida 33021 United States Details
University of Miami Univ Miami 2 Miami Florida 33136 United States Details
NorthWest Georgia Oncology Centers NW Georgia Oncology Marietta Georgia 30060 United States Details
Moanalua Medical Center. Attn: Oncology Dept SC Honolulu Hawaii 96817 United States Details
University of Chicago SC-3 Chicago Illinois 60637 United States Details
Norton Cancer Institute SC Louisville Kentucky 40202 United States Details
Sidney Kimmel Comprehensive Cancer Center Johns Hopkins Med Dept of Onc. Baltimore Maryland 21231 United States Details
Massachusetts General Hospital Onc Dept Boston Massachusetts 02114 United States Details
University of Michigan Comprehensive Cancer Center Onc Dept Ann Arbor Michigan 48109 United States Details
Washington University School of Medicine SC Saint Louis Missouri 63110 United States Details
Meridian Health Systems SC Neptune New Jersey 07754 United States Details
University of New Mexico Hospital SC-2 Albuquerque New Mexico 87106 United States Details
Clinical Research Alliance Lake Success New York 11042 United States Details
Duke University Medical Center Duke (SC) Durham North Carolina 27710 United States Details
Penn State University Milton S Hershey Medical Center Hershey Pennsylvania 17033 United States Details
Bon Secours Cancer Center SC Greenville South Carolina 29607 United States Details
Erlanger Medical Center SC Chattanooga Tennessee 37403 United States Details
Tennessee Oncology Tennessee Oncology (3) Nashville Tennessee 37203 United States Details
The Center for Cancer and Blood Disorders SC Fort Worth Texas 76104 United States Details
Methodist Hospital / Methodist Cancer Center Dept of Oncology Houston Texas 77030 United States Details
University of Texas MD Anderson Cancer Center SC-5 Houston Texas 77030 United States Details
Cancer Therapy and Research Center UT Health Science Center SC-4 San Antonio Texas 78229 United States Details
Brooke Army Medical Center SC San Antonio Texas 78234 United States Details
Northern Utah Cancer Associates Ogden Utah 84403-3105 United States Details
Bon Secours Virginia Health System Midlothian Virginia 23114 United States Details
Providence Regional Cancer Partnership Everett Washington 98201 United States Details
Kadlec Clinic Hematology and Oncology Kadlec Clinic Hematology & Onc Kennewick Washington 99336 United States Details
Northwest Medical Specialties Dept of Onc Tacoma Washington 98405 United States Details
University of Wisconsin / Paul P. Carbone Comp Cancer Center Univ Wisc 3 Madison Wisconsin 53792-6164 United States Details
Novartis Investigative Site Cordoba X5004FHP Argentina Details
Novartis Investigative Site Jujuy 4600 Argentina Details
Novartis Investigative Site La Rioja 5300 Argentina Details
Novartis Investigative Site Waratah New South Wales 2298 Australia Details
Novartis Investigative Site Box Hill Victoria 3128 Australia Details
Novartis Investigative Site Heidelberg Victoria 3084 Australia Details
Novartis Investigative Site Murdoch Western Australia 6150 Australia Details
Novartis Investigative Site Nedlands Western Australia 6009 Australia Details
Novartis Investigative Site Bruxelles 1000 Belgium Details
Novartis Investigative Site Leuven 3000 Belgium Details
Novartis Investigative Site Namur 5000 Belgium Details
Novartis Investigative Site Wilrijk 2610 Belgium Details
Novartis Investigative Site Londrina PR 86015-520 Brazil Details
Novartis Investigative Site Ijuí RS 98700-000 Brazil Details
Novartis Investigative Site Passo Fundo RS 99010-260 Brazil Details
Novartis Investigative Site Barretos SP 14784 400 Brazil Details
Novartis Investigative Site Sao Paulo SP 01317-002 Brazil Details
Novartis Investigative Site Sao Paulo SP 03102-002 Brazil Details
Novartis Investigative Site São Paulo SP 01509-900 Brazil Details
Novartis Investigative Site Sofia 1303 Bulgaria Details
Novartis Investigative Site Varna 9010 Bulgaria Details
Novartis Investigative Site Edmonton Alberta T6G 1Z2 Canada Details
Novartis Investigative Site Vancouver British Columbia V5Z 4E6 Canada Details
Novartis Investigative Site Ottawa Ontario K1H 8L6 Canada Details
Novartis Investigative Site Toronto Ontario M4N 3M5 Canada Details
Novartis Investigative Site Quebec G1S 4L8 Canada Details
Novartis Investigative Site Bogota 110221 Colombia Details
Novartis Investigative Site Monteria Colombia Details
Novartis Investigative Site Strasbourg Cedex Cedex F 67098 France Details
Novartis Investigative Site Caen Cedex 14021 France Details
Novartis Investigative Site Lille Cedex 59020 France Details
Novartis Investigative Site Lyon Cedex 69373 France Details
Novartis Investigative Site Montpellier Cedex 5 34298 France Details
Novartis Investigative Site Paris 75015 France Details
Novartis Investigative Site Rouen Cedex 1 76038 France Details
Novartis Investigative Site Toulouse Cedex 9 31059 France Details
Novartis Investigative Site Muehlhausen Thueringen 99974 Germany Details
Novartis Investigative Site Bonn 53111 Germany Details
Novartis Investigative Site Dresden 01307 Germany Details
Novartis Investigative Site Erlangen 91054 Germany Details
Novartis Investigative Site Essen 45136 Germany Details
Novartis Investigative Site Esslingen 73730 Germany Details
Novartis Investigative Site Kiel 24105 Germany Details
Novartis Investigative Site Leipzig 04103 Germany Details
Novartis Investigative Site Muenchen 81377 Germany Details
Novartis Investigative Site Offenbach 63069 Germany Details
Novartis Investigative Site Ravensburg 88214 Germany Details
Novartis Investigative Site Ulm 89081 Germany Details
Novartis Investigative Site Thessaloniki GR 54645 Greece Details
Novartis Investigative Site Heraklion Crete 711 10 Greece Details
Novartis Investigative Site Hong Kong Hong Kong Details
Novartis Investigative Site Kowloon Hong Kong Details
Novartis Investigative Site Budapest 1134 Hungary Details
Novartis Investigative Site Budapest H 1122 Hungary Details
Novartis Investigative Site Budapest H-1032 Hungary Details
Novartis Investigative Site Debrecen 4032 Hungary Details
Novartis Investigative Site Szeged 6720 Hungary Details
Novartis Investigative Site Szolnok H-5000 Hungary Details
Novartis Investigative Site Bangalore Karnataka 560 095 India Details
Novartis Investigative Site Nashik Maharashtra 422 004 India Details
Novartis Investigative Site Kolkatta West Bengal 700 053 India Details
Novartis Investigative Site Mumbai 400 012 India Details
Novartis Investigative Site L'Aquila AQ 67100 Italy Details
Novartis Investigative Site Benevento BN 82100 Italy Details
Novartis Investigative Site Bologna BO 40138 Italy Details
Novartis Investigative Site Cremona CR 26100 Italy Details
Novartis Investigative Site Catania CT 95124 Italy Details
Novartis Investigative Site Meldola FC 47014 Italy Details
Novartis Investigative Site Cona FE 44100 Italy Details
Novartis Investigative Site Genova GE 16132 Italy Details
Novartis Investigative Site Lecce LE 73100 Italy Details
Novartis Investigative Site Lucca LU 55100 Italy Details
Novartis Investigative Site Macerata MC 62100 Italy Details
Novartis Investigative Site Milano MI 20141 Italy Details
Novartis Investigative Site Perugia PG 06129 Italy Details
Novartis Investigative Site Prato PO 59100 Italy Details
Novartis Investigative Site Pavia PV 27100 Italy Details
Novartis Investigative Site Roma RM 00168 Italy Details
Novartis Investigative Site Candiolo TO 10060 Italy Details
Novartis Investigative Site Terni TR 05100 Italy Details
Novartis Investigative Site Udine UD 33100 Italy Details
Novartis Investigative Site Napoli 80131 Italy Details
Novartis Investigative Site Bundang Gu Gyeonggi Do 13620 Korea, Republic of Details
Novartis Investigative Site Gyeonggi do Korea 10408 Korea, Republic of Details
Novartis Investigative Site Seoul Korea 05505 Korea, Republic of Details
Novartis Investigative Site Seoul 03080 Korea, Republic of Details
Novartis Investigative Site Seoul 03722 Korea, Republic of Details
Novartis Investigative Site Seoul 06351 Korea, Republic of Details
Novartis Investigative Site El Chouf LBN 1503201002 Lebanon Details
Novartis Investigative Site Ashrafieh 166830 Lebanon Details
Novartis Investigative Site Beirut 1107 2020 Lebanon Details
Novartis Investigative Site Beirut 166378 Lebanon Details
Novartis Investigative Site Beirut Lebanon Details
Novartis Investigative Site Saida 652 Lebanon Details
Novartis Investigative Site Johor Bahru Johor 81100 Malaysia Details
Novartis Investigative Site Kuala Lumpur 59100 Malaysia Details
Novartis Investigative Site Metepec Edo. De México 01722 Mexico Details
Novartis Investigative Site Leon Guanajuato 37000 Mexico Details
Novartis Investigative Site Monterrey Nuevo Leon Monterrey 64710 Mexico Details
Novartis Investigative Site Gdansk 80 952 Poland Details
Novartis Investigative Site Konin 62 500 Poland Details
Novartis Investigative Site Lisboa 1099 023 Portugal Details
Novartis Investigative Site Lisboa 1400-038 Portugal Details
Novartis Investigative Site Lisboa 1500 650 Portugal Details
Novartis Investigative Site Porto 4200 319 Portugal Details
Novartis Investigative Site Porto 4200-072 Portugal Details
Novartis Investigative Site Arkhangelsk 163045 Russian Federation Details
Novartis Investigative Site Saint Petersburg 192148 Russian Federation Details
Novartis Investigative Site Riyadh 11426 Saudi Arabia Details
Novartis Investigative Site Singapore 119228 Singapore Details
Novartis Investigative Site Singapore 169610 Singapore Details
Novartis Investigative Site Elche Alicante 03203 Spain Details
Novartis Investigative Site Almeria Andalucia 04009 Spain Details
Novartis Investigative Site Malaga Andalucia 29010 Spain Details
Novartis Investigative Site Sabadell Barcelona 08208 Spain Details
Novartis Investigative Site Sant Joan Despi Barcelona 08970 Spain Details
Novartis Investigative Site Badalona Catalunya 08916 Spain Details
Novartis Investigative Site Barcelona Catalunya 08003 Spain Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Valencia Comunidad Valenciana 46010 Spain Details
Novartis Investigative Site Santiago de Compostela Galicia 15706 Spain Details
Novartis Investigative Site Mallorca Islas Baleares 07198 Spain Details
Novartis Investigative Site Alcorcon Madrid 28922 Spain Details
Novartis Investigative Site San Sebastian Pais Vasco 20080 Spain Details
Novartis Investigative Site Baracaldo Vizcaya 48903 Spain Details
Novartis Investigative Site Madrid 28033 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Madrid 28040 Spain Details
Novartis Investigative Site Geneve 1205 Switzerland Details
Novartis Investigative Site New Taipei City TWN 23561 Taiwan Details
Novartis Investigative Site Changhua 50006 Taiwan Details
Novartis Investigative Site Kaohsiung City 83301 Taiwan Details
Novartis Investigative Site Taipei 10002 Taiwan Details
Novartis Investigative Site Taipei 10449 Taiwan Details
Novartis Investigative Site Taipei 11217 Taiwan Details
Novartis Investigative Site Taipei Taiwan Details
Novartis Investigative Site Taoyuan 33305 Taiwan Details
Novartis Investigative Site Bangkok 10330 Thailand Details
Novartis Investigative Site Bangkok 10700 Thailand Details
Novartis Investigative Site Istanbul TUR 34098 Turkey Details
Novartis Investigative Site Adana 01160 Turkey Details
Novartis Investigative Site Ankara 06100 Turkey Details
Novartis Investigative Site Diyarbakir 21000 Turkey Details
Novartis Investigative Site Edirne 22030 Turkey Details
Novartis Investigative Site Izmir 35040 Turkey Details
Novartis Investigative Site Al Ain Abu Dhabi United Arab Emirates Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field